Interventional Cardiology Congenital/Structural HD

Specialties & Experience of this Expert Witness

Additional Information

John P. Cheatham, MD, MSCAI, FPICS, FACC, FAAP is Professor Emeritus, Department of Pediatrics, Cardiology at The Ohio State University College of Medicine. After graduating from the University of Oklahoma College of Medicine, he completed his residency at Boston Children’s Hospital, followed by a fellowship in Pediatric Cardiology at Texas Children’s Hospital in Houston. Dr. Cheatham’s area of expertise is transcatheter intervention and Hybrid therapy of newborns, children, and adults with complex congenital heart disease. He has pioneered several new techniques and devices in nonsurgical intervention, as well as being a world leader in developing new Hybrid therapies. Dr. Cheatham has been a principal investigator in numerous FDA sponsored clinical trials evaluating nonsurgical closure devices, stent therapy, and transcatheter pulmonary valves. Additionally, Dr. Cheatham designed the world’s first Hybrid Cardiac Catheterization Suites and advanced imaging equipment at Nationwide Children’s Hospital, which allows the interventionalist & cardiothoracic surgeon to perform combined therapy in order to improve clinical outcomes in patients referred to The Heart Center. He serves as a consultant to various medical companies and proctors, or teaches, new transcatheter techniques and devices to other physicians around the world. Dr. Cheatham served as Co-Director of The Heart Center & Director of Cardiac Catheterization & Interventional Therapies at Nationwide Children’s Hospital. He has implemented a formal physician exchange program with two of the leading medical institutions in China. In cooperation with China Red Cross, he is also the Foreign Director of the International Training Center for treatment of congenital heart disease in poor children. Dr. Cheatham is co-editor of two books and has authored more than 230 manuscripts, 30 book chapters, and over 540 national and international presentations. Dr. Cheatham was selected as one of the top 25 Innovators in Healthcare by Health Imaging & IT. He was also honored as the recipient of the Career Achievement Award at the prestigious 2007 PICS & AICS conference, attended by interventional cardiologists from all over the world. In 2015, Dr. Cheatham was named to the new class of Master Fellows of the Society for Cardiovascular Angiography and Interventions (MSCAI), the professional medical society for adult and pediatric invasive/interventional cardiologists. Dr. Cheatham was awarded the 2016 Career Contribution Award at Nationwide Children’s Hospital. Dr. Cheatham is semi-retired, however continues to serve as a medical consultant and proctor to several Medical and Device Companies worldwide. Most recently, he was the National P.I. of the Medtronic Harmony Transcatheter Pulmonary Valve and proctored many of the sites in the U.S. leading to FDA approval. In addition, he helped proctor the device in Japan leading to approval. He continues to retain his Ohio Medical License Dr. Cheatham has helped establish new Congenital Heart Centers in Orlando, FL (The Nemours Cardiac Center at Arnold Palmer Children's Hospital), and more recently in Columbus, OH (The Heart Center at Nationwide Children's Hospital where he served as a Co-Director and Director of Cardiac Catheterization & Interventions). The Hospital and Heart Center have been recognized as one of the leading Centers nationally and internationally.